Clinical Trials Directory

Trials / Completed

CompletedNCT02624882

Impact of Antibiotic Treatment of Group A Streptococcal Blistering Distal Dactylitis in Children

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
177 (actual)
Sponsor
Camille JUNG · Academic / Other
Sex
All
Age
1 Day – 18 Years
Healthy volunteers
Not accepted

Summary

Single-center prospective study to assess the clinical course of group A streptococcal blistering distal dactylitis in children after antibiotic treatment.

Detailed description

Blistering distal dactylitis are very common in children. About 60% are caused by Staphylococcus aureus and some are caused by Group A Streptococcus (GAS) or Streptococcus pyogenes. While these forms have been known for fifty years, few publications are interested in it. Some studies have confirmed that a single antibiotic treatment against the SGA allows the healing of these dactylitis but few surgical teams have adopted this strategy. As all streptococcal infections, they face the risk of acute complications (septicemia, streptococcal toxic shock, etc.) or late (post-streptococcal glomerulonephritis, acute rheumatic fever, etc.). The involvement of the SGA in these dactylitis is easy to demonstrate through the use of rapid GAS test already widely used in other GAS infections (tonsillitis, scarlet fever, streptococcal perianal infections). This study aims to assess the clinical course of positive GAS test blistering distal dactylitis in children after antibiotic treatment.

Conditions

Interventions

TypeNameDescription
PROCEDUREPositive rapid GAS testIf TDR positive, the child will be treated with antibiotics alone: * Amoxicillin 50mg / kg / day in 2 divided doses for 10 days (maximum dose 3 g / day in 2 divided doses) Or if allergic to penicillins and in the absence of cross-known allergy to cephalosporins * Cefpodoxime 8mg / kg / day in 2 divided doses for 10 days (maximum dose 400mg / day in 2 divided doses) J10 A control visit will review all the children included in the study. If the surgeon deems it necessary, the patient will be reviewed in consultation up to three months.
PROCEDURENegative rapid GAS testUsual care

Timeline

Start date
2015-11-01
Primary completion
2018-01-01
Completion
2018-03-01
First posted
2015-12-09
Last updated
2018-08-02

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02624882. Inclusion in this directory is not an endorsement.